机译:血浆激肽释放酶介导糖尿病大鼠视网膜血管功能障碍并诱导视网膜增厚。
Allen Clermont,1'2 Tamie J. Chilcote,3 Takeshi Kita,1,2 Jia Liu,1'2 Priscilla Riva,1 Sukanto Sinha,3 and Edward P. Feener1'2From the y Research Division, Joslin Diabetes Center, Boston, Massachusetts, the 2 Department of Medicine, Harvard Medical School, Boston, Massachusetts, and the 3 ActiveSite Pharmaceuticals, Berkeley, California.Corresponding author Edward P. Feener, edward.feener@joslin.harvard.edu.Received 8 September 2010 and accepted 21 February 2011.DOt 10.2337/dbl0-1260This article contains Supplementary Data online at http://diabetes. diabetesjournaIs.org^ookup/supp]/doi:10.2337/dbl0-1260/-/DCl.© 201 1 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creattvecommons.org/licenses/by -nc-ndtf.O/ for details.,;
机译:血浆激肽释放酶介导糖尿病大鼠视网膜血管功能障碍并诱导视网膜增厚。
机译:血浆激肽释放酶介导血管内皮生长因子诱导的视网膜功能障碍和增厚
机译:一种新颖的口服血浆Kallikrein(PKAL)抑制剂KV123833阻断VEGF介导的视网膜水肿中的视网膜模型中的视网膜血管超甲型
机译:半乳糖诱导的糖尿病性视网膜病变模型中视网膜毛细血管基底增厚的透射电镜研究
机译:在线粒体功能障碍引起的视网膜变性的体内模型中的神经保护策略。
机译:血浆激肽释放酶介导糖尿病大鼠视网膜血管功能障碍并诱导视网膜增厚。
机译:血浆激肽释放酶介导糖尿病大鼠视网膜血管功能障碍并诱导视网膜增厚。